Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Polskie Archiwum Medycyny Wewnetrznej

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.20452/PAMW.1113PMID 22157813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Definition, epidemiology, and classification of diabetes in children and adolescents

  2014cited by this paper
• Serum paraoxonase enzyme activity and oxidative stress in obese subjects.

  2011cited by this paper
• Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis.

  2011cited by this paper
• Arterial Stiffness, Lipoprotein Particle Size, and Lipoprotein Particle Concentration in Children with Type 1 Diabetes

  2010cited by this paper
• Anti‐oxidant properties of high‐density lipoprotein and atherosclerosis

  2010cited by this paper
• Paraoxonase 1 protects against protein N‐homocysteinylation in humans

  2010cited by this paper
• Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy

  2010cited by this paper
• Major lipids, apolipoproteins, and risk of vascular disease.

  2009cited by this paper
• Definition, epidemiology and classification of diabetes in children and adolescents

  2009cited by this paper
• Systemic oxidative stress is increased to a greater degree in young, obese women following consumption of a high fat meal

  2009cited by this paper
• Lipid disorders in type 1 diabetes.

  2009cited by this paper
• Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes

  2009cited by this paper
• Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women.

  2009cited by this paper
• HDL, lipid peroxidation, and atherosclerosis11 See referenced article, J. Lipid Res. 2009, 50: 716–722.

  2009cited by this paper
• The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy.

  2009cited by this paper
• Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.

  2008cited by this paper
• Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides

  2008cited by this paper
• Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications.

  2008cited by this paper
• Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?

  2007cited by this paper
• High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.

  2006cited by this paper
• Lipoprotein Composition in Children and Adolescents with Type 1 Diabetes Mellitus

  2005cited by this paper
• Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.

  2003cited by this paper
• Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood

  2002cited by this paper
• Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls

  2002cited by this paper
• Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.

  2001cited by this paper
• High-density lipoprotein composition and paraoxonase activity in Type I diabetes.

  2001cited by this paper
• Glycation impairs high-density lipoprotein function

  2000cited by this paper
• Consequences of the diabetic status on the oxidant/antioxidant balance.

  2000cited by this paper
• Oxidative stress and diabetes mellitus

  1999cited by this paper
• A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.

  1998cited by this paper
• Cytotoxic and genotoxic effects of 4-hydroxynonenal in cerebral endothelial cells.

  1997cited by this paper
• The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response.

  1996cited by this paper
• Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.

  1995cited by this paper
• Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)

  1995cited by this paper
• Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.

  1991cited by this paper
• Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

  1991cited by this paper
• Regulation of lipogenesis in adipocytes. Independent effects of thyroid hormones, cyclic AMP and insulin on the uptake of deoxy-D-glucose.

  1979cited by this paper
• Lipid Peroxidation and atherosclerosis

  1976cited by this paper

• Oxidative Stress, Hyperglycemia, Hyperlipidemia, and Hemostasis Impairment as Risk Factors for Diabetes in Rats: Investigating the Therapeutic Potential of Samwa (Cleome droserifolia)

  2025cites this paper
• Reishi Mushroom (Ganoderma lucidum) Intervention Improves Lipids Profile and Paraoxonase/Arylesterase Activities in Serum as well as Enhances Haemostatic Effects in Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• Effects of Securigera securidaca (L.) Degen & Dorfl seed extract combined with glibenclamide on paraoxonase1 activity, lipid profile and peroxidation, and cardiovascular risk indices in diabetic rats

  2019cites this paper
• Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province

  2019cites this paper
• Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

  2018cites this paper
• Serum Antioxidative Enzymes Levels and Oxidative Stress Products in Children and Adolescents with Type I Diabetes Mellitus

  2018cites this paper
• Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach

  2017cites this paper
• Association between promoter polymorphism (-108C>T) of paraoxonase1 gene and it's paraoxonase activity in patients with Type2 diabetes in northern Iran.

  2017cites this paper
• HDL functionality in type 1 diabetes.

  2017cites this paper
• The Association Between Circulating Levels of miRNA‐181a and Pancreatic Beta Cells Dysfunction via SMAD7 in Type 1 Diabetic Children and Adolescents

  2016cites this paper
• Effects of beta-glucan on protection of young and aged rats from renal ischemia and reperfusion injury.

  2016cites this paper
• Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.

  2015cites this paper
• Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus

  2014cites this paper
• Expression of mitochondrial superoxide dismutase in polymorphonuclear leukocytes from patients with type 1 diabetes with and without microvascular complications.

  2014cites this paper
• Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats

  2014cites this paper
• Antioxidant Status in Blood of Obese Children: The Relation between Trace Elements, Paraoxonase, and Arylesterase Values

  2014cites this paper
• Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study.

  2013cites this paper
• Antibodies against Nε-homocysteinylated proteins in patients on different methods of renal replacement therapy

  2013cites this paper
• Biochemical Evaluation of Oxidative Stress in Type 1 Diabetes

  2013cites this paper